ANVS
Annovis Bio Inc.
$2.32
$0.00(0.00%)
36
Overall
--
Value
36
Tech
--
Quality
Market Cap
$45.21M
Volume
170.39K
52W Range
$1.11 - $10.54
Target Price
$11.67
Order:
Income Statement
| Metric | Trend | Chart | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|
| OPERATING EXPENSES | |||||||
| Operating Expenses | $6.6M | $14.5M | $25.5M | $45.0M | $26.7M | ||
| Research & Development | $3.1M | $8.5M | $16.5M | $38.8M | $20.0M | ||
| Research Expense | $3.1M | $8.5M | $16.5M | $38.8M | $20.0M | ||
| Selling, General & Administrative | $3.6M | $6.1M | $9.0M | $6.2M | $6.7M | ||
| General & Administrative Expenses | $3.6M | $6.1M | $9.0M | $6.2M | $6.7M | ||
| Salaries & Wages | $1.9M | $4.7M | $9.2M | $4.6M | $3.8M | ||
| Other Operating Expenses | $41.6K | $14.5M | $66.8K | $100.0K | $100.0K | ||
| OPERATING INCOME | |||||||
| Operating income | $-6.6M | $-14.5M | $-25.5M | $-45.0M | $-26.7M | ||
| EBITDA | $-5.5M | $-14.5M | $-25.3M | $-56.2M | $-24.6M | ||
| NON-OPERATING ITEMS | |||||||
| Intinc | $47.2K | $13.3K | $182.7K | $667.9K | $331.8K | ||
| Net Non-Operating Interest Income/Expense | $47.2K | $13.3K | $182.7K | $667.9K | $331.8K | ||
| Gain on Sale of Securities | $-26.5K | -- | -- | $-11.8M | -- | ||
| Other Income/Expense | $-1.1M | $-36.8K | $-182.7K | $11.8M | $-3.6M | ||
| Other Special Charges | $1.2M | $36.8K | $182.7K | $-11.8M | $3.6M | ||
| PRE-TAX INCOME | |||||||
| EBIT | $-5.5M | $-14.5M | $-25.3M | $-56.2M | $-24.6M | ||
| Pre-Tax Income | $-5.5M | $-14.5M | $-25.3M | $-44.4M | $-26.4M | ||
| NET INCOME | |||||||
| Net Income | $-5.5M | $-14.5M | $-25.3M | $-56.2M | $-24.6M | ||
| Net Income (Continuing Operations) | $-5.5M | $-14.5M | $-25.3M | $-56.2M | $-24.6M | ||
| Net Income (Discontinued Operations) | $-5.5M | $-14.5M | $-25.3M | $-56.2M | $-24.6M | ||
| Net Income (Common Stockholders) | $-5.5M | $-14.5M | $-25.3M | $-56.2M | $-24.6M | ||
| Normalized Income | -- | -- | -- | -- | $-26.1M | ||
| TOTALS | |||||||
| Total Expenses | $6.6M | $14.5M | $25.5M | $45.0M | $26.7M | ||
| SHARE & EPS DATA | |||||||
| Average Shares Outstanding | $6.3M | $7.6M | $8.2M | $9.0M | $12.2M | ||
| Average Shares Outstanding (Diluted) | -- | $7.6M | $8.2M | $9.0M | $12.2M | ||
| Shares Outstanding | $6.9M | $8.2M | $8.2M | $11.0M | $19.5M | ||
| Basic EPS | $-0.87 | $-1.9 | $-3.1 | $-6.23 | $-2.02 | ||
| Basic EPS (Continuing Operations) | $-0.87 | $-1.9 | $-3.1 | $-6.23 | $-2.02 | ||
| Diluted EPS | $-0.87 | $-1.9 | $-3.1 | $-6.23 | $-2.31 | ||
| Diluted EPS (Continuing Operations) | -- | $-1.9 | $-3.1 | $-6.23 | $-2.31 | ||
| OTHER METRICS | |||||||
| Other Gand A | $3.6M | $6.1M | $9.0M | $6.2M | $6.7M | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ANVS | $2.32 | 0% | 170.39K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |